[HTML][HTML] Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
TG Richardson, GM Leyden, Q Wang, JA Bell… - PLoS …, 2022 - journals.plos.org
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
TG Richardson, GM Leyden, Q Wang, JA Bell… - PLoS Biology, 2022 - go.gale.com
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
[HTML][HTML] Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
TG Richardson, GM Leyden, Q Wang, JA Bell… - PLoS …, 2022 - ncbi.nlm.nih.gov
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
TG Richardson, GM Leyden, Q Wang, JA Bell… - PLoS …, 2022 - search.ebscohost.com
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
TG Richardson, GM Leyden, Q Wang, JA Bell… - Plos Biology, 2022 - europepmc.org
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Q Wang, JA Bell, B Elsworth - PLoS Biology, 2022 - search.proquest.com
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
TG Richardson, GM Leyden, Q Wang, JA Bell… - 2022 - agris.fao.org
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
TG Richardson, GM Leyden, Q Wang… - PLoS …, 2022 - pubmed.ncbi.nlm.nih.gov
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
GD Smith - PLoS Biology, 2022 - research-information.bris.ac.uk
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
TG Richardson, GM Leyden, Q Wang, JA Bell… - Plos Biology, 2022 - europepmc.org
Large-scale molecular profiling and genotyping provide a unique opportunity to
systematically compare the genetically predicted effects of therapeutic targets on the human …
systematically compare the genetically predicted effects of therapeutic targets on the human …